READ-ONLY DIGITIZATION RESULT
Impact of minimal residual disease on the outcome of hematopoietic stem cell transplantation for childhood acute lymphoblastic leukemia within the FORUM trial.
Haematologica · 2026-Jan-01 · PMID 40820816
Panel F提取完成待 EXE 对齐验证
Event-Free Survival
Figure 3. Outcome by minimal residual disease status at the time of hematopoietic stem cell transplantation according to immunophenotype. Overall survival (OS) (A), event-free survival (EFS) (B), cumulative incidence of relapse (CIR) (C), and transplant-related mortality (TRM) (D) for patients affected with B-lineage acute lymphoblastic leukemia (ALL). OS (E), EFS (F), CIR (G), and TRM (H) for those affected with T-lineage ALL. HSCT: hematopoietic stem cell transplantation; MRD: minimal residual disease; PCR: polymerase chain reaction; pos: positive; SE: Standard Error; TBI: total body irradiation; VP16: etoposide.
算法:legacy-0.5.0引擎:enhanced-linux
曲线数据
网页最多预览 200 行,完整数据请下载 CSV 或 JSON。
当前面板没有可预览的 `curves_mapped.csv` 数据。
历史版本(1)
重跑只新增版本,不覆盖旧结果;正式可用状态仅授予通过 EXE 基准或人工复核的版本。
| 版本 | 状态 | 验证 | 曲线 | 时间 |
|---|---|---|---|---|
| legacy-0.5.0 | complete | 待验证 | 2 | 2026-07-23T17:21:53+00:00 |